FindTrial
Sign In

Randomized controlled trial of lactose intolerance patients treated with milk lactose hydrolysis, soymilk on bone health in postmenopausal women

Bone health of postmenopausal and lactose intolerance patients treated with Milk lactose hydrolysis and Soymilk

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-16008140
Enrollment
Unknown
Registered
2016-03-22
Start date
2016-03-20
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoporosis

Interventions

Soymilk group:Soymilk
control group :nothing
Milk group :Mlik
Group of lactose intolerance :Lactose hydrolysis milk

Sponsors

Public Health College of Wuhan University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. The aged between 45 and 60 years old; 2. Bone loss in postmenopausal women; 3. Postmenopausal for 1 to 5 years without hormone therapy; 4. Voluntarily signed the study of informed consent.

Exclusion criteria

Exclusion criteria: 1. Women with natural menopause less than 1 years or more than 5 years; 2. Secondary osteoporosis patients; 3. Severe primary disease patients; 4. Mental disorders and cognitive impairment (dementia) patients; 5. Drugs used to affect bone metabolism in the past month; 6. Long term use of other related drugs or health care products (soy isoflavones,etc.); 7. Patients with fresh fractures and severe multiple fractures;

Design outcomes

Primary

MeasureTime frame
BMD;CTX;BALP;PINP;—

Countries

China

Contacts

Public ContactRong Shuang

Public Health College of Wuhan University of Science and Technology

moment-88@163.com+86 18571727264

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026